Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine

Credit: WJZ Baltimore

Duration: 00:31s 29 Jul 2021 0 shares 1 views

Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine

The FDA announced that they will allow Emergent Biosolutions to resume production of the Johnson and Johnson covid-19 vaccine on Thursday.

You might like

Related news coverage

Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine

Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine

The FDA announced that they will allow Emergent BioSolutions to resume production of the Johnson and Johnson covid-19 vaccine on..

WJZ Baltimore 29 Jul 2021

J&J recalls sunscreens after carcinogen found in some sprays

J&J recalls sunscreens after carcinogen found in some sprays

Johnson & Johnson is voluntarily recalling five Neutrogena and Aveeno brand aerosol sunscreen products after detecting a..

Reuters - Politics 15 Jul 2021

Advertisement